These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 24503718)
1. Curcumin synergistically enhances the radiosensitivity of human oral squamous cell carcinoma via suppression of radiation-induced NF-κB activity. Chiang IT; Liu YC; Hsu FT; Chien YC; Kao CH; Lin WJ; Chung JG; Hwang JJ Oncol Rep; 2014 Apr; 31(4):1729-37. PubMed ID: 24503718 [TBL] [Abstract][Full Text] [Related]
2. Sorafenib sensitizes human colorectal carcinoma to radiation via suppression of NF-κB expression in vitro and in vivo. Kuo YC; Lin WC; Chiang IT; Chang YF; Chen CW; Su SH; Chen CL; Hwang JJ Biomed Pharmacother; 2012 Feb; 66(1):12-20. PubMed ID: 22265104 [TBL] [Abstract][Full Text] [Related]
3. Synergistic effect of sorafenib with ionizing radiation on human oral cancer cells. Hsu FT; Chang B; Chiang IT; Wu TH; Hwang JJ In Vivo; 2014; 28(5):925-33. PubMed ID: 25189909 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy evaluation of curcumin on human oral squamous cell carcinoma xenograft using multimodalities of molecular imaging. Lin YC; Chen HW; Kuo YC; Chang YF; Lee YJ; Hwang JJ Am J Chin Med; 2010; 38(2):343-58. PubMed ID: 20387230 [TBL] [Abstract][Full Text] [Related]
5. Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells. Tamatani T; Azuma M; Motegi K; Takamaru N; Kawashima Y; Bando T Int J Oncol; 2007 Oct; 31(4):761-8. PubMed ID: 17786306 [TBL] [Abstract][Full Text] [Related]
6. Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products. Kunnumakkara AB; Diagaradjane P; Guha S; Deorukhkar A; Shentu S; Aggarwal BB; Krishnan S Clin Cancer Res; 2008 Apr; 14(7):2128-36. PubMed ID: 18381954 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the effect of p65 siRNA and curcumin in promoting apoptosis in esophageal squamous cell carcinoma cells and in nude mice. Tian F; Zhang C; Tian W; Jiang Y; Zhang X Oncol Rep; 2012 Jul; 28(1):232-40. PubMed ID: 22552693 [TBL] [Abstract][Full Text] [Related]
8. Curcumin potentiates laryngeal squamous carcinoma radiosensitivity via NF-ΚB inhibition by suppressing IKKγ expression. Deng XZ; Geng SS; Luo M; Chai JJ; Xu Y; Chen CL; Qiu L; Ke Q; Duan QW; Song SM; Shen L; Luo ZG J Recept Signal Transduct Res; 2020 Dec; 40(6):541-549. PubMed ID: 32515250 [No Abstract] [Full Text] [Related]
9. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer. Sreekanth CN; Bava SV; Sreekumar E; Anto RJ Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920 [TBL] [Abstract][Full Text] [Related]
10. Curcumin Sensitizes Hepatocellular Carcinoma Cells to Radiation via Suppression of Radiation-Induced NF-κB Activity. Hsu FT; Liu YC; Liu TT; Hwang JJ Biomed Res Int; 2015; 2015():363671. PubMed ID: 26539482 [TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 inhibitor, nimesulide, improves radiation treatment against non-small cell lung cancer both in vitro and in vivo. Grimes KR; Warren GW; Fang F; Xu Y; St Clair WH Oncol Rep; 2006 Oct; 16(4):771-6. PubMed ID: 16969492 [TBL] [Abstract][Full Text] [Related]
12. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway. Wang D; Veena MS; Stevenson K; Tang C; Ho B; Suh JD; Duarte VM; Faull KF; Mehta K; Srivatsan ES; Wang MB Clin Cancer Res; 2008 Oct; 14(19):6228-36. PubMed ID: 18829502 [TBL] [Abstract][Full Text] [Related]
13. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823 [TBL] [Abstract][Full Text] [Related]
14. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice. Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373 [TBL] [Abstract][Full Text] [Related]
15. Curcumin enhances the response of non-Hodgkin's lymphoma cells to ionizing radiation through further induction of cell cycle arrest at the G2/M phase and inhibition of mTOR phosphorylation. Qiao Q; Jiang Y; Li G Oncol Rep; 2013 Jan; 29(1):380-6. PubMed ID: 23117293 [TBL] [Abstract][Full Text] [Related]
16. Anti-tumor activity of dehydroxymethylepoxyquinomicin against human oral squamous cell carcinoma cell lines in vitro and in vivo. Yasuda A; Kondo S; Nagumo T; Tsukamoto H; Mukudai Y; Umezawa K; Shintani S Oral Oncol; 2011 May; 47(5):334-9. PubMed ID: 21459660 [TBL] [Abstract][Full Text] [Related]
17. Curcumin enhances the radiosensitivity of renal cancer cells by suppressing NF-κB signaling pathway. Li G; Wang Z; Chong T; Yang J; Li H; Chen H Biomed Pharmacother; 2017 Oct; 94():974-981. PubMed ID: 28810535 [TBL] [Abstract][Full Text] [Related]
18. Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Li L; Braiteh FS; Kurzrock R Cancer; 2005 Sep; 104(6):1322-31. PubMed ID: 16092118 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma. Gong H; Song L; Lin C; Liu A; Lin X; Wu J; Li M; Li J Clin Cancer Res; 2013 Mar; 19(5):1083-93. PubMed ID: 23319823 [TBL] [Abstract][Full Text] [Related]
20. Glycerol enhances radiosensitivity in a human oral squamous cell carcinoma cell line (Ca9-22) bearing a mutant p53 gene via Bax-mediated induction of apoptosis. Imai Y; Ohnishi K; Yasumoto J; Kajiwara A; Yamakawa N; Takahashi A; Ohnishi T; Kirita T Oral Oncol; 2005 Jul; 41(6):631-6. PubMed ID: 15975526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]